BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 27566169)

  • 1. Expression of PACAP and PAC1 Receptor in Normal Human Thyroid Gland and in Thyroid Papillary Carcinoma.
    Bardosi S; Bardosi A; Nagy Z; Reglodi D
    J Mol Neurosci; 2016 Oct; 60(2):171-8. PubMed ID: 27566169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary adenylyl cyclase-activating polypeptide (PACAP) and its receptor (PAC1-R) in the cochlea: evidence for specific transcript expression of PAC1-R splice variants in rat microdissected cochlear subfractions.
    Abu-Hamdan MD; Drescher MJ; Ramakrishnan NA; Khan KM; Toma VS; Hatfield JS; Drescher DG
    Neuroscience; 2006 Jun; 140(1):147-61. PubMed ID: 16626868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
    Lutz EM; Ronaldson E; Shaw P; Johnson MS; Holland PJ; Mitchell R
    Mol Cell Neurosci; 2006 Feb; 31(2):193-209. PubMed ID: 16226889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
    Scaldaferri ML; Modesti A; Palumbo C; Ulisse S; Fabbri A; Piccione E; Frajese G; Moretti C
    Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue.
    García-Fernández MO; Collado B; Bodega G; Cortés J; Ruíz-Villaespesa A; Carmena MJ; Prieto JC
    Gynecol Endocrinol; 2005 Jun; 20(6):327-33. PubMed ID: 16019382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAC1 receptors mediate pituitary adenylate cyclase-activating polypeptide- and progesterone-facilitated receptivity in female rats.
    Apostolakis EM; Riherd DN; O'Malley BW
    Mol Endocrinol; 2005 Nov; 19(11):2798-811. PubMed ID: 15976009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
    Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
    Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PACAP and PAC1 receptor in brain development and behavior.
    Shen S; Gehlert DR; Collier DA
    Neuropeptides; 2013 Dec; 47(6):421-30. PubMed ID: 24220567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
    Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary adenylyl cyclase-activating polypeptide (PACAP) and its receptor (PAC1-R) are positioned to modulate afferent signaling in the cochlea.
    Drescher MJ; Drescher DG; Khan KM; Hatfield JS; Ramakrishnan NA; Abu-Hamdan MD; Lemonnier LA
    Neuroscience; 2006 Sep; 142(1):139-64. PubMed ID: 16876955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental changes in the hypothalamic mRNA expression levels of PACAP and its receptor PAC1 and their sensitivity to fasting in male and female rats.
    Iwasa T; Matsuzaki T; Tungalagsuvd A; Munkhzaya M; Yiliyasi M; Kato T; Kuwahara A; Irahara M
    Int J Dev Neurosci; 2016 Aug; 52():33-7. PubMed ID: 27181029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxycycline exerted neuroprotective activity by enhancing the activation of neuropeptide GPCR PAC1.
    Yu R; Zheng L; Cui Y; Zhang H; Ye H
    Neuropharmacology; 2016 Apr; 103():1-15. PubMed ID: 26700245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PACAP and type I PACAP receptors in human prostate cancer tissue.
    Moretti C; Mammi C; Frajese GV; Mariani S; Gnessi L; Arizzi M; Wannenes F; Frajese G
    Ann N Y Acad Sci; 2006 Jul; 1070():440-9. PubMed ID: 16888207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary adenylate cyclase activating polypeptide-mediated intracrine signaling in the testicular germ cells.
    Li M; Funahashi H; Mbikay M; Shioda S; Arimura A
    Endocrine; 2004 Feb; 23(1):59-75. PubMed ID: 15034198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GnRH-induced PACAP and PAC1 receptor expression in pituitary gonadotrophs: a possible role in the regulation of gonadotropin subunit gene expression.
    Purwana IN; Kanasaki H; Oride A; Mijiddorj T; Shintani N; Hashimoto H; Baba A; Miyazaki K
    Peptides; 2010 Sep; 31(9):1748-55. PubMed ID: 20553777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary adenylate cyclase-activating peptide induces neurite outgrowth in cultured monkey trigeminal ganglion cells: involvement of receptor PAC1.
    Nakajima E; Walkup RD; Fujii A; Shearer TR; Azuma M
    Mol Vis; 2013; 19():174-83. PubMed ID: 23378731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus.
    Mounien L; Bizet P; Boutelet I; Gourcerol G; Fournier A; Vaudry H; Jégou S
    Neuroscience; 2006 Nov; 143(1):155-63. PubMed ID: 16962718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
    Reubi JC; Läderach U; Waser B; Gebbers JO; Robberecht P; Laissue JA
    Cancer Res; 2000 Jun; 60(11):3105-12. PubMed ID: 10850463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.